INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 158 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2015. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $56,000 | +33.3% | 12,036 | 0.0% | 0.00% | – |
| Q4 2018 | $42,000 | -65.3% | 12,036 | 0.0% | 0.00% | – |
| Q3 2018 | $121,000 | +39.1% | 12,036 | 0.0% | 0.00% | – |
| Q2 2018 | $87,000 | +22.5% | 12,036 | +2.4% | 0.00% | – |
| Q1 2018 | $71,000 | -37.2% | 11,751 | 0.0% | 0.00% | – |
| Q4 2017 | $113,000 | +8.7% | 11,751 | 0.0% | 0.00% | – |
| Q3 2017 | $104,000 | -30.2% | 11,751 | 0.0% | 0.00% | – |
| Q2 2017 | $149,000 | -46.6% | 11,751 | +20.7% | 0.00% | -100.0% |
| Q4 2015 | $279,000 | +0.7% | 9,732 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $277,000 | -32.8% | 9,732 | -15.1% | 0.00% | 0.0% |
| Q2 2015 | $412,000 | +33.3% | 11,458 | +115.3% | 0.00% | 0.0% |
| Q1 2015 | $309,000 | +37.9% | 5,321 | 0.0% | 0.00% | – |
| Q4 2014 | $224,000 | +8.7% | 5,321 | 0.0% | 0.00% | – |
| Q3 2014 | $206,000 | – | 5,321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 3,028,354 | $30,526,000 | 0.37% |
| Engineers Gate Manager LP | 96,105 | $969,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 61,600 | $621,000 | 0.06% |
| GAM Holding AG | 83,940 | $846,000 | 0.03% |
| SHELL ASSET MANAGEMENT CO | 90,282 | $910,000 | 0.02% |
| SFMG, LLC | 11,994 | $107,000 | 0.02% |
| QS Investors, LLC | 159,133 | $1,604,000 | 0.02% |
| Winslow, Evans & Crocker, Inc. | 4,060 | $42,000 | 0.01% |
| PANAGORA ASSET MANAGEMENT INC | 285,646 | $2,879,000 | 0.01% |
| PEAK6 Investments LLC | 225,800 | $2,276,000 | 0.01% |